MCAT Bio/Biochem study materials
MCAT Bio/Biochem study resources

Lactate Dehydrogenase Isoforms in a Hypoxic Tumor Fragment

MCAT Bio/Biochem · Put your knowledge to work in context.

All case studies

Lactate Dehydrogenase Isoforms in a Hypoxic Tumor Fragment

A research team perfuses a 2 mm cube of tumor tissue with glucose-free buffer containing 5 mM lactate and 0.5 mM pyruvate, then measures NADH/NAD+ in the cytosolic and mitochondrial compartments. Cytosolic NADH/NAD+ is 40:1; mitochondrial matrix NADH/NAD+ is 3:1. The tissue expresses predominantly the H (heart, oxygen-sensitive) isoform of lactate dehydrogenase (LDH), which is inhibited by high pyruvate and favors lactate oxidation less than the M isoform. A separate control fragment is perfused with 5 mM glucose under normoxia and shows a cytosolic NADH/NAD+ of 0.5:1. The cells lack functional mitochondrial pyruvate carriers and rely on the malate-aspartate shuttle, which is also downregulated by 70%.

1. Predict the net direction of the LDH reaction in the hypoxic fragment and justify it quantitatively.

Read the worked answer

Use the reaction lactate + NAD+ ⇌ pyruvate + NADH + H+. The mass-action ratio Q = [pyruvate][NADH]/([lactate][NAD+]). With [NADH]/[NAD+] = 40 and [pyruvate]/[lactate] = 0.5/5 = 0.1, Q = 0.1 × 40 = 4. Compare with the equilibrium constant Keq (≈ 2.8 × 10⁻⁴ M at pH 7 for the pyruvate-reducing direction written as pyruvate + NADH → lactate + NAD+; the ratio [lactate][NAD+]/[pyruvate][NADH] is ≈ 3.6 × 10³). The observed ratio [lactate][NAD+]/[pyruvate][NADH] = 10/40 = 0.25, far below the equilibrium ratio, so the reaction is displaced toward pyruvate formation (lactate oxidation) in thermodynamic terms. However, the H isoform is inhibited by pyruvate and disfavors lactate oxidation kinetically; with pyruvate present at 0.5 mM and the shuttle downregulated, NADH cannot be reoxidized efficiently, so net flux is small and the system sits near equilibrium. The exam-level judgment: thermodynamics says oxidize lactate, but enzyme isoform kinetics and shuttle limitation mean flux is negligible-the tissue is trapped, not rescued by lactate.

2. A drug is added that increases mitochondrial pyruvate uptake 5-fold. Predict the effect on cytosolic NADH/NAD+ and on the tissue's ATP yield, assuming oxidative phosphorylation is intact.

Read the worked answer

Restoring pyruvate entry lets pyruvate dehydrogenase and the TCA cycle consume pyruvate, pulling the LDH reaction toward pyruvate (lactate oxidation) and regenerating NAD+ in the cytosol only if a shuttle moves reducing equivalents in. Since the malate-aspartate shuttle is 70% downregulated, the rate-limiting step is shuttle capacity, not pyruvate supply. Expect a modest drop in cytosolic NADH/NAD+ (perhaps from 40:1 toward 10–20:1) but not normalization. ATP yield rises per pyruvate oxidized (~12.5 ATP vs 0 net from lactate fermentation), but the ceiling is set by shuttle flux; the 5-fold increase in pyruvate uptake exceeds shuttle capacity, so excess pyruvate accumulates and may inhibit LDH further (H isoform). Key judgment: increasing substrate supply does not relieve a downstream capacity limit-the shuttle is the bottleneck.